A. H. Rubenstein

4.3k total citations · 1 hit paper
69 papers, 3.4k citations indexed

About

A. H. Rubenstein is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, A. H. Rubenstein has authored 69 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Surgery and 21 papers in Genetics. Recurrent topics in A. H. Rubenstein's work include Pancreatic function and diabetes (35 papers), Diabetes Management and Research (22 papers) and Diabetes and associated disorders (19 papers). A. H. Rubenstein is often cited by papers focused on Pancreatic function and diabetes (35 papers), Diabetes Management and Research (22 papers) and Diabetes and associated disorders (19 papers). A. H. Rubenstein collaborates with scholars based in United States, South Africa and Denmark. A. H. Rubenstein's co-authors include David L. Horwitz, Howard S. Tager, Mary E. Mako, J I Starr, William G. Blackard, K. S. Polonsky, Jonathan B. Jaspan, B. Gonen, Boas Gonen and H. Rochman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

A. H. Rubenstein

69 papers receiving 3.0k citations

Hit Papers

Proinsulin, insulin, and C-peptide concentrations in huma... 1975 2026 1992 2009 1975 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. H. Rubenstein United States 30 1.7k 1.2k 943 798 532 69 3.4k
Sheldon J. Bleicher United States 15 1.5k 0.9× 1.1k 0.9× 904 1.0× 509 0.6× 986 1.9× 26 3.6k
Gerald R. Faloona United States 29 2.1k 1.3× 1.6k 1.3× 917 1.0× 465 0.6× 1.0k 1.9× 42 4.1k
Kam‐Seng Lau United States 7 1.3k 0.8× 1.1k 0.9× 1.2k 1.3× 550 0.7× 919 1.7× 10 3.9k
Chester W. Gottlieb United States 10 1.3k 0.8× 1.1k 0.9× 1.3k 1.4× 564 0.7× 926 1.7× 13 4.0k
R Assan France 31 1.9k 1.1× 1.7k 1.4× 744 0.8× 1.4k 1.7× 737 1.4× 200 4.2k
Kinori Kosáka Japan 38 2.6k 1.6× 1.5k 1.2× 1.3k 1.4× 1.1k 1.4× 911 1.7× 162 4.8k
Richard G. Larkins Australia 32 936 0.6× 770 0.6× 876 0.9× 392 0.5× 592 1.1× 139 3.2k
Robert A. Kreisberg United States 29 1.5k 0.9× 737 0.6× 765 0.8× 790 1.0× 1.1k 2.2× 81 3.6k
Paolo Brunetti Italy 33 2.1k 1.3× 1.5k 1.2× 934 1.0× 947 1.2× 641 1.2× 73 4.0k
P Vague France 35 1.8k 1.1× 1.2k 1.0× 736 0.8× 670 0.8× 924 1.7× 95 4.3k

Countries citing papers authored by A. H. Rubenstein

Since Specialization
Citations

This map shows the geographic impact of A. H. Rubenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Rubenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Rubenstein more than expected).

Fields of papers citing papers by A. H. Rubenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Rubenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Rubenstein. The network helps show where A. H. Rubenstein may publish in the future.

Co-authorship network of co-authors of A. H. Rubenstein

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Rubenstein. A scholar is included among the top collaborators of A. H. Rubenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Rubenstein. A. H. Rubenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shapiro, E Timothy, G I Bell, K. S. Polonsky, et al.. (1990). Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.. Journal of Clinical Investigation. 85(5). 1672–1679. 99 indexed citations
2.
Bergenstal, Richard M., Peter H. Morse, A. H. Rubenstein, et al.. (1988). Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. JAMA. 260(1). 37–41. 90 indexed citations
3.
Carroll, Raymond J., Robert E. Hammer, Shu Jin Chan, et al.. (1988). A mutant human proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway.. Proceedings of the National Academy of Sciences. 85(23). 8943–8947. 113 indexed citations
4.
Shoelson, Steven E., M Ficková, Masakazu Haneda, et al.. (1983). Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution.. Proceedings of the National Academy of Sciences. 80(24). 7390–7394. 51 indexed citations
5.
Shoelson, Steven E., Masakazu Haneda, P.M. Blix, et al.. (1983). Three mutant insulins in man. Nature. 302(5908). 540–543. 121 indexed citations
6.
Valenta, Lubomir J., Harvey Eisenberg, Darla R. Miller, et al.. (1982). The value of artificial beta cell in the management of insulinoma.. PubMed. 137(1). 67–75. 1 indexed citations
7.
Jaspan, Jonathan B., K. S. Polonsky, Sven Röjdmark, et al.. (1981). Hepatic Extraction of Plasma Immunoreactive Glucagon Components: Predilection for 3500-dalton Glucagon Metabolism by the Liver. Diabetes. 30(9). 767–772. 15 indexed citations
8.
Zeidler, Adina, et al.. (1976). HETEROGENEITY OF PLASMA GLUCAGON: PATTERNS IN PATIENTS WITH CHRONIC RENAL FAILURE AND DIABETES.. The Journal of Clinical Endocrinology & Metabolism. 42(1). 173–176. 64 indexed citations
9.
Katz, Adrian I., M. D. Lindheimer, Mary E. Mako, & A. H. Rubenstein. (1975). Peripheral metabolism of insulin, proinsulin, and C-peptide in the pregnant rat.. Journal of Clinical Investigation. 56(6). 1608–1614. 23 indexed citations
10.
Tager, Howard S., A. H. Rubenstein, & Donald F. Steiner. (1975). [28] Methods for the assessment of peptide precursors. Studies on insulin biosynthesis. Methods in enzymology on CD-ROM/Methods in enzymology. 37. 326–345. 14 indexed citations
11.
Rubenstein, A. H., et al.. (1974). INSULIN SUPPRESSION. The Lancet. 304(7887). 1021–1021. 186 indexed citations
12.
Seftel, H. C., et al.. (1973). Metabolic features of Johannesburg Bantu with myocardial infarction.. PubMed. 47(35). 1571–5. 5 indexed citations
13.
Melani, F., A. H. Rubenstein, & Donald F. Steiner. (1971). Proinsulin and C-Peptide in Human Serum. PubMed. 7 Suppl 1. 159–172. 3 indexed citations
14.
Metzger, Allan L. & A. H. Rubenstein. (1970). Reversible Cerebral Oedema Complicating Diabetic Ketoacidosis. BMJ. 3(5725). 746–747. 25 indexed citations
15.
Spitz, I. M., et al.. (1970). The Blood Sugar and Serum Insulin Response to Intravenous Glucagon in Chronic Renal Failure. Experimental Biology and Medicine. 134(1). 142–145. 2 indexed citations
16.
Rubenstein, A. H., et al.. (1968). EVIDENCE FOR PROINSULIN IN HUMAN URINE AND SERUM. The Lancet. 291(7556). 1353–1355. 86 indexed citations
17.
Rubenstein, A. H., et al.. (1966). HYPOGLYCÆMIA PRECIPITATED BY PROPRANOLOL. The Lancet. 288(7478). 1389–1390. 124 indexed citations
18.
Abrahams, Cyril, et al.. (1964). HEPATOCELLULAR LIPOFUSCIN AFTER EXCESSIVE INGESTION OF ANALGESICS. The Lancet. 284(7360). 621–622. 17 indexed citations
19.
Rubenstein, A. H., et al.. (1962). MANGANESE-INDUCED HYPOGLYCÆMIA. The Lancet. 280(7270). 1348–1351. 51 indexed citations
20.
Rubenstein, A. H., et al.. (1962). Hypoglycæmia induced by Manganese. Nature. 194(4824). 188–189. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026